Shares of Medigus Ltd. (MDGS) are rising over 28% in pre-market today, after the company announced the signing of a collaboration agreement with L-1 Systems Ltd. for the joint commercialization of various COVID-19 related products and solutions to governmental agencies and institutional healthcare organizations.
The agreement marks the second collaboration between Medigus and L1 Systems following the previously disclosed agreement for the commercialization and licensing of the MUSE system in Latin America.
Further, the collaboration seeks to capitalize on the synergies derived from L1 System's strong supply chain connections and Medigus' medical experience and network.
The stock has been trading between $0.83 and $3.48 in the past one year, and closed Friday's trade at $1.90, up 56 cents or 41.79%. MDSG is currently trading at $2.45, up 55 cents or 28.95% in the pre-market trading session.
For comments and feedback: editorial@rttnews.com